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It has been claimed over the years—most recently in this journal and several others—that neuronal
degeneration in adult brain arising during chronic alcohol exposure is, or is likely to be, via
“excitotoxicity” (Chandrasekar, 2013; Mehta et al., 2013; Crews and Vetreno, 2014). A purpose
of this opinion piece is to reinforce a view, noted earlier (Collins and Neafsey, 2012), that an
excitotoxic mechanism underlying alcoholic neurodamage in the mature brain has never been
experimentally proven in vivo. Indeed, pharmacological results in neuronal degeneration studies
with repetitively intoxicated (binged) adult rats indicate that the excitotoxic route is insignificant—
more about this later.
Discovered over 4½ decades ago (Olney, 1969), excitotoxicity relates principally to a deleterious
property of the brain’s major excitatory neurotransmitter, L-glutamate. When hyper-elevated
extracellularly for a variety of reasons, glutamate can overstimulate neuronal N-methyl-D-aspartate
(NMDA) receptors, causing cellular degeneration; sometimes increased receptor content could
also be a factor. Specifically, excessively stimulated NMDA receptors—being calcium channels—
facilitate the cytosolic accumulation of calcium ions, and elevated intraneuronal calcium triggers
neuropathological events or associated accomplices that include, among others, increased protease,
nuclease and phospholipase activities, oxygen- and nitrogen-free radicals (oxidative/nitrosative
stress), membrane lipid peroxidation, and perhaps reductions in antioxidant defenses (Pina-Crespo
et al., 2014). The ensuing neuronal degeneration can be apoptotic, necrotic, or a continuum of both.
Excitotoxicity is considered a chief mechanism for brain damage in acquired insults/models such as
stroke, trauma, status epilepticus, hypoglycemia, and hyperglycemia. It also may have a role in the
chronic neurotoxicity of toxicants such as methyl mercury and trimethyltin, and of severe vitamin
deficiencies (notably, thiamine). In any event, the sine qua non proof of excitotoxicity-mediated
neuronal degeneration in these and other experimental conditions is pharmacological—blockade of
glutamatergic (especially NMDA) receptors and calcium elevations by effective antagonists should
significantly suppress or abrogate neuronal demise.
The original proposals that excitotoxicity causes chronic alcohol-dependent brain damage were
based on evidence entirely from brain/neuronal cultures or cell lines, and not in in vivo adult
models (Lovinger, 1993; Tsai et al., 1995). Numerous culture-based reports have appeared since
those first experiments (e.g., Hendricson et al., 2007)—most recently, studies with neonatal or early
adolescent-age hippocampal slice cultures treated with high alcohol for a week or more, followed
by withdrawal, in which NMDA receptor antagonism reduces neurodegeneration (Stepanyan
et al., 2008; Reynolds et al., 2015). However, these and other brain cultures, being perinatal
and/or developmental and (in the case of dispersed cultures or cell lines) often lacking glial and
cerebrovascular components, may well be insufficient or even inappropriate models for alcohol’s
neurotoxic mechanisms in the intact adult brain. Among dissimilarities in outcomes, neuronal
apoptosis can be prominent in binge alcohol-treated rodent brain cultures, but is largely absent
in brain regions exhibiting neuronal degeneration in a repetitive binge-intoxicated adult rat model
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to be described subsequently (Obernier et al., 2002). Also,
changes in systemic proinflammatory agents such as certain
cytokines that are linked to neuronal degeneration are of course
not present with in vitromodels.
Proof of excitotoxicity-associated neuronal degeneration in
adult brain from alcohol requires in vivo studies employing
NMDA receptor antagonists, but such studies have been rare.
For discussion purposes, two general approaches have been used
to study chronic alcohol-induced brain damage. In the first,
voluntary or semi-voluntary oral intake of alcohol in water
or liquid diets for weeks or sometimes months, the maximal
blood alcohol concentration (BAC) reached is considered
experimentally moderate, generally encompassing 80–150mg/dl;
among variations, “drinking-in-the-dark” or regulated episodic
access can achieve higher values. Since the seminal reports in
the 1980’s by the late Don Walker and collaborators, these
adult models are documented to incur brain neuronal loss from
chronic alcohol ingestion.
Amid many studies using these drinking models or their
variations, none appears to have examined in detail the
quantitative impact of NMDA receptor antagonism on alcohol-
dependent brain neuronal degeneration and/or loss. We could
locate only a few chronic alcohol ingestion studies that used
NMDA receptor antagonists, and these provide insufficient
information on excitotoxicity per se. In the first of these,
the influence of weeks of alcohol+liquid diet intake on brain
injury arising from ischemia/reperfusion employed adult rats co-
treated with memantine, a relatively specific NMDA receptor
antagonist; however, memantine’s effects on the neuronal loss or
damage expected from the alcohol intake alone were unspecified
(Zhao et al., 2011). An earlier study, albeit with rats of late
adolescent-age, used alcohol+liquid diet ingestion for 2 weeks
(maximal BAC, 126mg/dl) to assess the effect of NMDA
receptor antagonism on brain oxidative stress indicators (Bondy
and Guo, 1996). Unsurprisingly, alcohol intake significantly
increased brain oxidative stress as reflected in regional declines
of antioxidants glutathione and superoxide dismutase, but co-
administration of MK-801, another potent NMDA receptor
antagonist, failed to inhibit the decreases. Since MK-801
should have interrupted oxidative stress if derived from NMDA
receptor-linked excitotoxicity, the authors opined that “the pro-
oxidant properties of ethanol may thus act independently of its
actions upon the NMDA receptor.”
The second basic approach to realizing neuronal degeneration
in adult animals has been involuntary alcohol intoxication, either
chronic (>8 days) or subchronic (∼4 days), principally via
intragastric (i.g.) intubation, vapor inhalation, or intraperitoneal
(i.p.) injection. Again, different doses, schedules and durations
have been employed for alcohol delivery. Often the maximal
BAC in rodents given the typically medium to high doses (3–
5 g alcohol/kg/d i.g. or i.p.) is similar to those in severe chronic
alcoholics—in the approximate range of 300–450+mg/dl.
Such concentrations, although seemingly high, match those
seen in toxicology assays in active, severe alcoholics. If
alcohol is provided to adult rats over 4 days via thrice-
daily intragastric binges (developed to study dependence-related
seizures, Majchrowicz, 1975), neuronal degeneration that, similar
to human alcoholism, is prominent in hippocampus and
temporal cortex (Collins et al., 1996).
Anticipating excitotoxicity in this binge model, we first tested
MK-801’s effects and, as noted in an initial abstract, found no
observable neuroprotection in adult male rats (Neafsey et al.,
1989). Expansion of the studies led to full reports detailing
the lack of significant prevention of the neurodamage by MK-
801 in the 4-day model (Corso et al., 1998) as well as in a
modified once-a-day gavage technique over 7–10 days, which
afforded the regional degeneration with considerably lower
maximal BACs (Collins et al., 1998). Also not neuroprotective
in the 4-day model were antagonists of glutamatergic AMPA
receptors (DNQX) and neuronal calcium channels (nimodipine),
and inhibitors of nitric oxide synthases—pathways connected
to the excitotoxic mechanism (Zou et al., 1996; Corso et al.,
1998). Subsequently, lack of evidence for excitotoxicity in the
Majcrowicz binge model was verified in R. Eskay’s laboratory
at NIAAA using memantine as well as nimodipine (Hamelink
et al., 2005). However, brain oxidative stress is critical to
the observed neuropathology, since antioxidants are effective
protectants (Hamelink et al., 2005; Crews et al., 2006). Thus, as
with the liquid diet experiments by Bondy and Guo mentioned
above, the ostensible free radical elevations do not appear to be
driven by an excitotoxic mechanism.
We were unable to find other studies of involuntary
intoxication in a mammalian model that specifically examine
neurotoxicity with NMDA receptor antagonists. However,
alcohol vapor-exposed adult drosophila sustained degeneration
of olfactory neurons that was termed excitotoxic due to
blockade by lithium (French and Heberlein, 2009). Among
its many targets, lithium inhibits glycogen synthase kinase-
3 (GSK3), which some reports associate with potentiation of
excitotoxicity. However, it would have been more compelling in
this non-mammalian model if blockade had been accomplished
with an NMDA receptor antagonist, as there are a number
of explanations for lithium’s neuroprotective results besides
excitotoxic inhibition (and GSK3 can mediate cell death by
routes other than excitotoxicity). Prior to this drosophila study,
lithium neuroprotection against alcohol had been reported only
in primary neuronal cell cultures or developing brain.
Continuing the subject of developing CNS, alcohol-induced
neuronal pathology might well involve excitotoxic mechanisms
in fetal or perinatal brain, as indicated by the rodent brain
culture studies cited earlier; in vivo verification is provided
with 6-day old rat pups given acute alcohol binges, in which
MK801 treatment significantly attenuated later neurobehavioral
impairments (Thomas et al., 2002 and earlier reports from
the Riley laboratory). Parenthetically, neuronal protection
is unreported in the above citation, but is mentioned in
a concurrent RSA abstract with another NMDA receptor
antagonist. Furthermore, many investigations have detailed
numerous brain glutamate/NMDA receptor-related changes and
neurobehaviors in adult rodents during prolonged alcohol
exposure (Tsai and Coyle, 1998)—e.g., alterations in vivo in
glutamatergic neurotransmission, NMDA receptor densities,
synaptic and neuroadaptive phenomena such as pruning, ionic
disturbances or flux, neuroplasticity, and withdrawal-associated
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seizures, among others. Moreover, NMDA receptor antagonism
can significantly perturb many of these alcohol-induced brain
effects (Nelson et al., 2005; Holmes et al., 2012; Navarro
and Mandyam, 2015). Thus, a functional hyperglutamatergic
state is associated with chronic alcohol in several regions of
adult brain. We further acknowledge that alcohol treatments
might potentiate excitotoxic mechanisms promoted by other
insults such as brain ischemia/reperfusion (Zhao et al., 2011);
additionally, brain damage in the Wernicke-Korsakoff syndrome
in alcoholics might include a prominent excitotoxic component,
since neurodamage from experimental thiamine deficiency,
which primarily underlies Wernicke’s, can be antagonized by
NMDA receptor blockade.
However, with respect to adult brain neuronal degeneration
from short-term daily binges, pharmacological findings
repeatedly fail to support excitotoxicity in the mechanistic
chain-of-events. In contrast, brain damage in such models
(with both adult rats and mice) is linked to oxidative
stress-linked mechanisms apparently encompassing pro-
inflammatory/neuroimmune cytokine and lipid pathways
(Crews and Vetreno, 2014; Tajuddin et al., 2014). Admittedly,
these short term adult animal procedures might be viewed as
inadequate models for alcoholic brain damage arising from
decades of dependence—but they are still closer to the human
condition than neonatal brain cultures. If excitotoxicity is
critical to neurodamage in adult models of prolonged daily
alcohol intake that mirror chronic alcoholism, experimental
verification is needed with receptor antagonists or perhaps
receptor silencing using RNA interference. Until convincingly
demonstrated in these models, excitotoxicity in alcohol-
induced adult brain damage remains solely speculative and
unproven.
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